Comprehensive revenue comparison of pure robotic vs. hybrid robotic surgery for sigmoid colon and rectosigmoid cancer.

IF 1.6 4区医学 Q2 SURGERY

Surgery Today Pub Date : 2025-07-15 DOI:10.1007/s00595-025-03097-9

Toshiyuki Fukuda, Masakatsu Numata, Tatsunosuke Harada, Shota Izukawa, Yosuke Atsumi, Keisuke Kazama, Yusuke Suwa, Syo Sato, Takafumi Kumamoto, Tsutomu Sato, Aya Saito

{"title":"Comprehensive revenue comparison of pure robotic vs. hybrid robotic surgery for sigmoid colon and rectosigmoid cancer.","authors":"Toshiyuki Fukuda, Masakatsu Numata, Tatsunosuke Harada, Shota Izukawa, Yosuke Atsumi, Keisuke Kazama, Yusuke Suwa, Syo Sato, Takafumi Kumamoto, Tsutomu Sato, Aya Saito","doi":"10.1007/s00595-025-03097-9","DOIUrl":null,"url":null,"abstract":"Purpose: Robotic surgery (RS) in colorectal procedures is growing but remains costly. This study evaluated the cost-saving potential of hybrid robotic surgery (hybrid RS), which integrates laparoscopic devices, compared to conventional RS (pure RS).Methods: This single-center retrospective study (2022-2024) compared pure RS and hybrid RS for sigmoid and rectosigmoid cancers. Propensity score matching minimizes bias. Total revenue is calculated as the total fee minus the total cost.Results: After matching, 20 patients (10 per group) were analyzed. Hybrid RS improved total revenue ($3515.15 vs. $3229.33) by reducing the total cost ($3652.45 vs. $4061.33), mainly through lower material costs for staplers and ultrasonic devices. The operative time was shorter, and the safety and pathological outcomes were comparable.Conclusions: Hybrid RS enhances cost efficiency by substituting expensive devices with affordable alternatives, supporting wider adoption of robotic surgery. Further validation using larger studies is necessary.","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery Today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00595-025-03097-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Robotic surgery (RS) in colorectal procedures is growing but remains costly. This study evaluated the cost-saving potential of hybrid robotic surgery (hybrid RS), which integrates laparoscopic devices, compared to conventional RS (pure RS).

Methods: This single-center retrospective study (2022-2024) compared pure RS and hybrid RS for sigmoid and rectosigmoid cancers. Propensity score matching minimizes bias. Total revenue is calculated as the total fee minus the total cost.

Results: After matching, 20 patients (10 per group) were analyzed. Hybrid RS improved total revenue ($3515.15 vs. $3229.33) by reducing the total cost ($3652.45 vs. $4061.33), mainly through lower material costs for staplers and ultrasonic devices. The operative time was shorter, and the safety and pathological outcomes were comparable.

Conclusions: Hybrid RS enhances cost efficiency by substituting expensive devices with affordable alternatives, supporting wider adoption of robotic surgery. Further validation using larger studies is necessary.

查看原文本刊更多论文

纯机器人与混合机器人手术治疗乙状结肠和直肠乙状结肠癌的综合收益比较。

目的：机器人手术（RS）在结直肠手术中正在增长，但仍然昂贵。本研究评估了混合机器人手术（hybrid RS）的成本节约潜力，它集成了腹腔镜设备，与传统的RS（纯RS）相比。方法：这项单中心回顾性研究（2022-2024）比较了纯RS和混合RS治疗乙状结肠和直肠乙状结肠癌。倾向评分匹配使偏差最小化。总收入计算为总费用减去总成本。结果：配对后，分析20例患者（每组10例）。混合RS通过降低总成本（3652.45美元对4061.33美元）提高了总收入（3515.15美元对3229.33美元），主要是通过降低订书机和超声波设备的材料成本。手术时间较短，安全性和病理结果相当。结论：混合RS通过用可负担的替代品替代昂贵的设备来提高成本效益，支持机器人手术的广泛采用。有必要使用更大规模的研究进一步验证。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgery Today 医学-外科

CiteScore

4.90

自引率

4.00%

发文量

208

审稿时长

1 months

期刊介绍： Surgery Today is the official journal of the Japan Surgical Society. The main purpose of the journal is to provide a place for the publication of high-quality papers documenting recent advances and new developments in all fields of surgery, both clinical and experimental. The journal welcomes original papers, review articles, and short communications, as well as short technical reports("How to do it"). The "How to do it" section will includes short articles on methods or techniques recommended for practical surgery. Papers submitted to the journal are reviewed by an international editorial board. Field of interest: All fields of surgery.